{"transactions":[{"id":811533,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-04-09T21:25:08.000Z","date":"2026-04-08","kind":"sale","planned":false,"acquired":false,"shares":1134,"price":5.4,"value":6123.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025."}],"balance_after":94827,"source":{"system":"sec-edgar","filing":"0001213900-26-042079","document":"marketforms-72911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026042079/marketforms-72911.xml","form_type":"4"}},{"id":819735,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R&D Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:05:11.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":22598,"price":5.26,"value":118865.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.31, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":95961,"source":{"system":"sec-edgar","filing":"0001213900-26-039328","document":"marketforms-72854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026039328/marketforms-72854.xml","form_type":"4"}},{"id":930096,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-27T21:10:06.000Z","date":"2026-01-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3724,"price":6.67,"value":24839.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 24, 2025."}],"balance_after":118559,"source":{"system":"sec-edgar","filing":"0001213900-26-008223","document":"marketforms-71933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026008223/marketforms-71933.xml","form_type":"4"}},{"id":933450,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-22T21:30:23.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":6578,"price":5.6,"value":36836.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":122283,"source":{"system":"sec-edgar","filing":"0001213900-26-006708","document":"marketforms-71770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006708/marketforms-71770.xml","form_type":"4"}},{"id":934325,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:36:09.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":180000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001213900-26-006225","document":"marketforms-71895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006225/marketforms-71895.xml","form_type":"4"}},{"id":934324,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2026-01-21T21:36:09.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":128861,"source":{"system":"sec-edgar","filing":"0001213900-26-006225","document":"marketforms-71895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390026006225/marketforms-71895.xml","form_type":"4"}},{"id":1188881,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-03-28T20:12:14.000Z","date":"2025-03-26","kind":"sale","planned":true,"acquired":false,"shares":21224,"price":4.53,"value":96144.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.69, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":98861,"source":{"system":"sec-edgar","filing":"0001013762-25-004101","document":"marketforms-68923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000101376225004101/marketforms-68923.xml","form_type":"4"}},{"id":1293115,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T21:05:15.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":146000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 24, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":146000,"derivative":{"exercise_price":4.53,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":146000},"source":{"system":"sec-edgar","filing":"0001213900-25-007532","document":"marketforms-67931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025007532/marketforms-67931.xml","form_type":"4"}},{"id":1293114,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-28T21:05:15.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 24, 2025."}],"balance_after":126639,"source":{"system":"sec-edgar","filing":"0001213900-25-007532","document":"marketforms-67931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025007532/marketforms-67931.xml","form_type":"4"}},{"id":1296445,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-23T21:05:11.000Z","date":"2025-01-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":6554,"price":4.76,"value":31197.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024."}],"balance_after":95585,"source":{"system":"sec-edgar","filing":"0001213900-25-005963","document":"marketforms-67894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025005963/marketforms-67894.xml","form_type":"4"}},{"id":1308171,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2025-01-07T21:20:12.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2157,"price":6.14,"value":13243.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":102139,"source":{"system":"sec-edgar","filing":"0001213900-25-001646","document":"marketforms-67734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390025001646/marketforms-67734.xml","form_type":"4"}},{"id":1673137,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T21:05:26.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":137000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":137000,"derivative":{"exercise_price":1.91,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":137000},"source":{"system":"sec-edgar","filing":"0001213900-24-005724","document":"marketforms-64336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390024005724/marketforms-64336.xml","form_type":"4"}},{"id":1673136,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:26.000Z","date":"2024-01-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3049,"price":1.91,"value":5823.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023."}],"balance_after":104296,"source":{"system":"sec-edgar","filing":"0001213900-24-005724","document":"marketforms-64336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390024005724/marketforms-64336.xml","form_type":"4"}},{"id":1673135,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2024-01-23T21:05:26.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024."}],"balance_after":107345,"source":{"system":"sec-edgar","filing":"0001213900-24-005724","document":"marketforms-64336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390024005724/marketforms-64336.xml","form_type":"4"}},{"id":1680109,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2024-01-12T21:05:38.000Z","date":"2024-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5229,"price":2.39,"value":12497.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020."}],"balance_after":84345,"source":{"system":"sec-edgar","filing":"0001213900-24-003335","document":"marketforms-64051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390024003335/marketforms-64051.xml","form_type":"4"}},{"id":1685583,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2024-01-05T21:35:21.000Z","date":"2024-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1899,"price":2.17,"value":4120.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":89574,"source":{"system":"sec-edgar","filing":"0001213900-24-001546","document":"marketforms-63997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390024001546/marketforms-63997.xml","form_type":"4"}},{"id":2049809,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T21:00:10.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":119300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 19, 2023 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":119300,"derivative":{"exercise_price":3.02,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":119300},"source":{"system":"sec-edgar","filing":"0001213900-23-004082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390023004082/ownership.xml","form_type":"4"}},{"id":2049808,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2023-01-20T21:00:10.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2023."}],"balance_after":91473,"source":{"system":"sec-edgar","filing":"0001213900-23-004082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390023004082/ownership.xml","form_type":"4"}},{"id":2056556,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2023-01-11T21:05:42.000Z","date":"2023-01-10","kind":"tax_withholding","acquired":false,"shares":5225,"price":3,"value":15675.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020."}],"balance_after":71573,"source":{"system":"sec-edgar","filing":"0001213900-23-002266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390023002266/ownership.xml","form_type":"4"}},{"id":2068217,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2023-01-04T21:26:36.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":2159,"price":2.8,"value":6045.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022."}],"balance_after":76798,"source":{"system":"sec-edgar","filing":"0001213900-23-000857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000121390023000857/ownership.xml","form_type":"4"}},{"id":2436900,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2022-01-12T22:20:10.000Z","date":"2022-01-10","kind":"tax_withholding","acquired":false,"shares":4603,"price":6.27,"value":28860.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted\nto the Reporting Person on January 10, 2020."}],"balance_after":78957,"source":{"system":"sec-edgar","filing":"0001209191-22-003091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919122003091/doc4.xml","form_type":"4"}},{"id":2444275,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:37:40.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":84800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 3, 2022 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":84800,"derivative":{"exercise_price":6.9,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":84800},"source":{"system":"sec-edgar","filing":"0001209191-22-001725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919122001725/doc4.xml","form_type":"4"}},{"id":2444274,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2022-01-05T21:37:40.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":14100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock.  The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 3, 2022."}],"balance_after":83560,"source":{"system":"sec-edgar","filing":"0001209191-22-001725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919122001725/doc4.xml","form_type":"4"}},{"id":2900934,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T20:04:43.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on the one year anniversary of January 19, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":75000,"derivative":{"exercise_price":19.82,"expiration_date":"2031-01-18","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-004652","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919121004652/doc4.xml","form_type":"4"}},{"id":2908412,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chf Scientific Operations Off"}}],"security":"Common Stock","published_at":"2021-01-13T22:19:22.000Z","date":"2021-01-11","kind":"tax_withholding","acquired":false,"shares":4653,"price":21.16,"value":98457.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted\nto the Reporting Person on January 10, 2020."}],"balance_after":69460,"source":{"system":"sec-edgar","filing":"0001209191-21-003448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919121003448/doc4.xml","form_type":"4"}},{"id":3312684,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Research"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:11:18.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":9537,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Merger in exchange for an employee stock option to acquire 50,000 shares of ArTara Sub Common Stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"22,000 (44%) of the shares subject to the option shall vest immediately. The remaining 28,000 shares shall vest in twenty seven (27) approximately equal increments beginning on the first day of the first calendar month following the Date of Grant, September 17, 2019, and then on the first day of each of the next twenty six (26) months thereafter a (\"Vesting Date\"), if Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being December 1, 2021, all of the Option Shares which had not vested by then will vest and become exercisable)."}],"balance_after":9537,"derivative":{"exercise_price":9.18,"expiration_date":"2019-09-16","underlying":"Common Stock","underlying_shares":9537},"source":{"system":"sec-edgar","filing":"0001209191-20-003233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919120003233/doc4.xml","form_type":"4"}},{"id":3312683,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Research"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:11:18.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":9537,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Merger in exchange for an employee stock option to acquire 50,000 shares of ArTara Sub Common Stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option shall vest in forty eight (48) approximately equal increments of one thousand forty one (1,041) shares beginning on the first day of the first calendar month following January 1, 2019, and then on the first day of each of the next forty seven (47) months thereafter (each a \"Vesting Date\"), if Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being December 1, 2022), all of the Option Shares which had not vested by then (being not less than 1,073 Option Shares) will vest and become exercisable."}],"balance_after":9537,"derivative":{"exercise_price":9.18,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":9537},"source":{"system":"sec-edgar","filing":"0001209191-20-003233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919120003233/doc4.xml","form_type":"4"}},{"id":3312682,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Research"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:11:18.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":19075,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for an employee stock option to acquire 100,000 shares of ArTara Sub Common Stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option shall vest monthly following August 1, 2018, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":19075,"derivative":{"exercise_price":9.18,"expiration_date":"2028-07-11","underlying":"Common Stock","underlying_shares":19075},"source":{"system":"sec-edgar","filing":"0001209191-20-003233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919120003233/doc4.xml","form_type":"4"}},{"id":3312681,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Research"}}],"security":"Common Stock","published_at":"2020-01-14T00:11:18.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of Issuer's common stock. 25% of the shares vest on each one-year anniversary of January 10, 2020."}],"balance_after":74113,"source":{"system":"sec-edgar","filing":"0001209191-20-003233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919120003233/doc4.xml","form_type":"4"}},{"id":3312680,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":53087,"kind":"person","name":"Zummo Jacqueline","position":1,"cik":"0001798929","reported_name":"Zummo Jacqueline","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, Research"}}],"security":"Common Stock","published_at":"2020-01-14T00:11:18.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":28613,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were received in exchange for 150,000 shares of ArTara Sub Common Stock in connection with the Merger."}],"balance_after":28613,"source":{"system":"sec-edgar","filing":"0001209191-20-003233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798929/000120919120003233/doc4.xml","form_type":"4"}}]}